alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 74, Number 20 (Monday, February 2, 2009)]
[Notices]
[Pages 5820-5821]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-2181]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

International Trade Administration


House Ear Institute, et al.; Notice of Consolidated Decision on 
Applications for Duty-Free Entry of Electron Microscopes

    This is a decision consolidated pursuant to Section 6(c) of the 
Educational, Scientific, and Cultural Materials Importation Act of 1966 
(Pub. L. 89-651, as amended by Pub. L. 106-36; 80 Stat. 897; 15 CFR 
part 301). Related records can be viewed between 8:30 a.m. and 5 p.m. 
in Room 2104, U.S. Department of Commerce, 14th and Constitution 
Avenue, NW., Washington, DC.
    Docket Number: 08-055. Applicant: House Ear Institute, Los Angeles, 
CA 90057. Instrument: Electron Microscope, Model Technai G2 20 TEM. 
Manufacturer: FEI Company, Czech Republic. Intended Use: See notice at 
73 FR 74703, December 9, 2008.
    Docket Number: 08-057. Applicant: Louisiana State University, Baton 
Rouge, LA 70803. Instrument: Electron Microscope, Model FEI Quanta 3D 
FEG DualBeam. Manufacturer: FEI Company, the Netherlands. Intended Use: 
See notice at 73 FR 70961, November 24, 2008.

[[Page 5821]]

    Docket Number: 08-058. Applicant: University of New Mexico, 
Albuquerque, NM 87131. Instrument: Electron Microscope, Model FEI 
Quanta 3D FEG Focused Ion Beam. Manufacturer: FEI Company, the 
Netherlands. Intended Use: See notice at 73 FR 70961, November 24, 
2008.
    Comments: None received. Decision: Approved. No instrument of 
equivalent scientific value to the foreign instrument, for such 
purposes as these instruments are intended to be used, was being 
manufactured in the United States at the time the instruments were 
ordered. Reasons: Each foreign instrument is an electron microscope and 
is intended for research or scientific educational uses requiring an 
electron microscope. We know of no electron microscope, or any other 
instrument suited to these purposes, which was being manufactured in 
the United States at the time of order of each instrument.

    Dated: January 26, 2009.
Christopher D. Cassel,
Acting Director, Subsidies Enforcement Office, Import Administration.
 [FR Doc. E9-2181 Filed 1-30-09; 8:45 am]
BILLING CODE 3510-DS-P
----

Judgment of the Court of First Instance of 30 November 2005 — Almdudler-Limonade v OHIM

(Case T-12/04) (1)

(Community trade mark - Three-dimensional mark - Shape of a lemonade bottle - Refusal to register - Article 7(1)(b) of Regulation (EC) No 40/94)

(2006/C 36/65)

Language of the case: German

Parties

Applicant: Almdudler-Limonade A. & S. Klein (Vienna, Austria) (represented by: G. Schönherr, lawyer)

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: G. Schneider, Agent)

Action

brought against the decision of the Second Chamber of the Board of Appeal of OHIM of 5 November 2003 (Case R 490/2003-2) in relation to the registration of a three-dimensional mark in the shape of a lemonade bottle

Operative part of the judgment

The Court:

----

(1)OJ C 106, 30.4.2004.

----
#### The TRAVELERS INDEMNITY COMPANY v. Dr. Norman S. HUNT.

No. 65128.

Supreme Court of Louisiana.

Sept. 4, 1979.

In re Dr. Norman S. Hunt, applying for certiorari, or writ of review to the Court of Appeal, Fourth Circuit. Parish of Orleans. 371 So.2d 342.

Writ denied.

DIXON, J., would grant on assignment No. 1.
HomeDirect Line for American Business...Investment Opportunities in Egypt’s Green Economy

# 									Investment Opportunities in Egypt’s Green Economy							

Direct Line Event

Bureau of Economic and Business Affairs

December 8, 2021

**Topic:**Investment Opportunities in Egypt’s Green Economy

**Host:**Ambassador Jonathan Cohen

**Date and Time:**December 8th, 9:00 a.m. (New York) 6:00 a.m. (Los Angeles) 4:00 p.m. (Cairo)****

**Brief Description of Call:**Join Ambassador Cohen, the Egyptian Center for Economic Studies, the American Chamber of Commerce in Egypt, and the U.S. – Egypt Business Council to learn about investment opportunities in green hydrogen, waste to energy, and other renewable energies; desalination; sustainable transportation; pollution mitigation; and more.

Tags

Bureau of Economic and Business AffairsDirect LineEgypt

Back to Top
crda-ex1026_680.htm



 

Exhibit 10.26

 

Director Compensation Summary Term Sheet

 

During calendar year 2020, each non-employee member of the Board was entitled to receive an aggregate of $140,000 in cash and restricted stock. The cash portion of the compensation was paid quarterly in $12,500 increments. The remainder of such compensation was paid in restricted shares of the Company’s Class A common stock, and vested on December 31, 2020 to individuals who were on the Board on December 31, 2020.

 

In addition to the foregoing, for 2020 each non-employee director was entitled to receive $1,500 for each Board or committee meeting attended. Further, the Chairman of each of the Executive Committee, the Governance Committee, and the Compensation Committee was paid an additional retainer of $2,500 per quarter. The Chairman of the Audit Committee was paid a retainer of $4,250 per quarter. In addition to the amounts set forth above, the Chairman of the Board was entitled to receive (i) a retainer of $100,000, payable quarterly in restricted shares of the Company’s Class A Common Stock pursuant to the terms of the Crawford & Company Non-Employee Director Stock Plan.

 

During calendar year 2021, each non-employee member of the Board is entitled to receive an aggregate of $140,000 in cash and restricted stock. The cash portion of the compensation will be paid quarterly in $12,500 increments. The remainder of such compensation will be paid in restricted shares of the Company’s Class A common stock, and will vest on December 31, 2021 to individuals who are on the Board on December 31, 2021.

 

In addition to the foregoing, for 2021 each non-employee director is entitled to receive $1,500 for each Board or committee meeting attended. Further, the Chairman of each of the Executive Committee, the Governance Committee, and the Compensation Committee is paid an additional retainer of $2,500 per quarter. The Chairman of the Audit Committee is paid a retainer of $4,250 per quarter. In addition to the amounts set forth above, the Chairman of the Board is entitled to receive a retainer of $100,000, payable quarterly in restricted shares of the Company’s Class A Common Stock pursuant to the terms of the Crawford & Company Non-Employee Director Stock Plan.
Prudential Financial, Inc. Non-Employee Director Compensation Summary



 Exhibit 10.34 
 EXHIBIT A 
 Prudential Financial, Inc. Non-Employee Director Compensation Summary 

(As adopted on December 9, 2008) 
  

	 	•	 	 Upon becoming a director, each non-employee director (a “Director”) receives a one-time grant of $100,000 in Prudential Financial stock units that are
deferred until retirement1 from the Board. 


  

	 	•	 	 Each Director receives an annual retainer of $200,000 of which 50% is automatically deferred in units of Prudential Financial stock payable upon retirement under
The Prudential Deferred Compensation Plan for Non-Employee Directors. The remaining 50% may be deferred at the Director’s option. 


  

	 	•	 	 All Committee Chairpersons receive an additional $15,000 retainer (50% of which is automatically deferred in stock units). 


  

	 	•	 	 The Lead or Presiding Director receives an annual retainer of $25,000 (50% of which is automatically deferred in stock units). 


  

	 	•	 	 Audit Committee members receive an annual committee retainer of $25,000 (50% of which is automatically deferred in stock units). 


  

	 	•	 	 Members of each standing Board Committee other than the Audit Committee and the Executive Committee and of any non-standing Committee of Directors that may be
established from time to time receive an annual committee retainer of $10,000 (50% of which is automatically deferred in stock units). 


  

	 	•	 	 There are no meeting fees, other than fees for attending meetings of the Community Resources Committee (which generally meets on a day separate from Board
meetings). Members of this committee receive $1,250 per meeting. 


  
  

	 1
	 For purposes of this policy, “retirement” means the earlier of termination of service on the Board or the
year in which a director reaches the age of 70  1/2. Once a director reaches the age of 70  1/2, he or she may elect to receive his or her annual compensation on a current or deferred basis and may elect to receive such annual
compensation in cash or deferred stock units (or any combination thereof).
# C_2006022EN.01000202.xml

| 28.1.2006 | EN | Official Journal of the European Union | C 22/2 |
| --- | --- | --- | --- |

28.1.2006

EN

Official Journal of the European Union

C 22/2

---

JUDGMENT OF THE COURT

JUDGMENT OF THE COURT

(Sixth Chamber)

of 17 November 2005

in Case C-73/05: Commission of the European Communities v French Republic (1)

1

(Failure of a Member State to fulfil obligations - Directive 2000/34/EC - Organisation of working time)

(2006/C 22/04)

Language of the case: French

In Case C-73/05 Commission of the European Communities (Agent: N. Yerrell) v French Republic (Agents: G. de Bergues and O. Christmann) — action under Article 226 EC for failure to fulfil obligations, brought on 15 February 2005 — the Court (Sixth Chamber), composed of A. Borg Barthet (Rapporteur), acting as President of the Sixth Chamber, U. Lõhmus and A. Ó Caoimh, Judges; J. Kokott, Advocate General; R. Grass, Registrar, gave a judgment on 17 November 2005, in which it:

| 1. | Declares that, by failing to adopt all the laws, regulations and administrative measures necessary to comply with Directive 2000/34/EC of the European Parliament and of the Council of 22 June 2000 amending Council Directive 93/104/EC concerning certain aspects of the organisation of working time to cover sectors and activities excluded from that Directive, the French Republic has failed to fulfil its obligations under that directive; |
| --- | --- |

1.

Declares that, by failing to adopt all the laws, regulations and administrative measures necessary to comply with Directive 2000/34/EC of the European Parliament and of the Council of 22 June 2000 amending Council Directive 93/104/EC concerning certain aspects of the organisation of working time to cover sectors and activities excluded from that Directive, the French Republic has failed to fulfil its obligations under that directive;

| 2. | Orders the French Republic to pay the costs. |
| --- | --- |

2.

Orders the French Republic to pay the costs.

---

(1)  OJ C 82 of 2.4.2005.

1

---
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted
from the consolidated balance sheet and statements of operations
filed as part of the Quarterly Report on Form 10-QSB for the
quarter ended July 31, 1999 and is qualified in its
entirety by reference to such report on Form 10-QSB.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                  9-MOS
<FISCAL-YEAR-END>                          OCT-31-1999
<PERIOD-END>                               JUL-31-1999
<CASH>                                         963,588
<SECURITIES>                                   100,297
<RECEIVABLES>                                4,352,230
<ALLOWANCES>                                         0
<INVENTORY>                                    439,075
<CURRENT-ASSETS>                             6,203,524
<PP&E>                                       3,412,775
<DEPRECIATION>                               1,330,616
<TOTAL-ASSETS>                              16,659,962
<CURRENT-LIABILITIES>                        2,678,140
<BONDS>                                      7,451,474
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           214
<OTHER-SE>                                   6,530,134
<TOTAL-LIABILITY-AND-EQUITY>                16,659,962
<SALES>                                      8,559,485
<TOTAL-REVENUES>                             8,754,210
<CGS>                                        3,232,682
<TOTAL-COSTS>                                5,080,546
<OTHER-EXPENSES>                                14,137
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             615,181
<INCOME-PRETAX>                               (188,336)
<INCOME-TAX>                                   (79,363)
<INCOME-CONTINUING>                           (108,973)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (108,973)
<EPS-BASIC>                                     (.05)
<EPS-DILUTED>                                     (.05)


</TABLE>
§ 10.3 Definitions. For the purposes of this part, the following definitions apply: *340B Administrative Dispute Resolution (ADR) process* means a process used to resolve the following types of claims, including any issues that assist the 340B ADR Panel in resolving such claims: ( 1 ) Claims by covered entities that may have been overcharged for covered outpatient drugs purchased from manufacturers; and
( 2 ) Claims by manufacturers of 340B drugs, after a manufacturer has conducted an audit of a covered entity (pursuant to section 340B(a)(5)(C) of the Public Health Service Act (PHS Act)), that a covered entity may have violated the prohibitions against duplicate discounts or diversion.
*Administrative Dispute Resolution Panel (340B ADR Panel)* means a decision-making body within the Health Resources and Services Administration's Office of Pharmacy Affairs that reviews and makes decisions for claims filed through the 340B ADR process.
*Average Manufacturer Price (AMP)* has the meaning set forth in section 1927(k)(1) of the Social Security Act, as implemented in 42 CFR 447.504.
*Ceiling price* means the maximum statutory price established under section 340B(a)(1) of the PHSA and this section.
*Claim* means a written allegation filed by or on behalf of a covered entity or by a manufacturer for resolution under the 340B ADR process.
*CMS* is the Centers for Medicare & Medicaid Services.
*Consolidated claim* means a claim resulting from combining multiple manufacturers' claims against the same covered entity.
*Covered entity* means an entity that is listed within section 340B(a)(4) of the PHSA, meets the requirements under section 340B(a)(5) of the PHSA, and is registered and listed in the 340B database.
*Covered outpatient drug* has the meaning set forth in section 1927(k) of the Social Security Act.
*Joint claim* means a claim resulting from combining multiple covered entities' claims (or claims from their membership organizations or associations) against the same manufacturer for the same drug or drugs.
*Manufacturer* has the meaning set forth in section 1927(k) of the Social Security Act, as implemented in 42 CFR 447.502.
*National Drug Code (NDC)* has the meaning set forth in 42 CFR 447.502.
*Office of Pharmacy Affairs (OPA)* means the office, or any successor office assigned to administer the 340B Program, within the Health Resources and Services Administration, or any successor agency, that oversees the 340B Program.
*Pharmaceutical Pricing Agreement (PPA)* means an agreement described in section 340B(a)(1) of the PHSA.
*Quarter* refers to a calendar quarter unless otherwise specified.
*Secretary* means the Secretary of the Department of Health and Human Services and any other officer of employee of the Department of Health and Human Services to whom the authority involved has been delegated.
[82 FR 1229, Jan. 5, 2017, as amended at 85 FR 80644, Dec. 14, 2020; 89 FR 28657, Apr. 19, 2024]
# Saint Vincent and the Grenadines

54 items

        -    Report  		2022 Trafficking in Persons Report: St. Vincent and the Grenadines	  July 19, 2022 
        -    Special Briefing via Telephone  		Telephonic Press Briefing on Food Security across Latin America with Jose Fernandez, Under Secretary of State for Economic Growth, Energy, and the Environment	  Jose W. FernandezJune 23, 2022 
        -    Report  		2021 Report on International Religious Freedom: Saint Vincent and the Grenadines	  June 2, 2022 
        -    Special Briefing via Telephone  		Telephonic Press Briefing with Juan Gonzalez, National Security Council Senior Director for the Western Hemisphere and Brian A. Nichols, Assistant Secretary of State for Western Hemisphere Affairs, Bureau of Western Hemisphere Affairs	  Brian A. NicholsJune 1, 2022 
        -    Report  		2021 Country Reports on Human Rights Practices: Saint Vincent and the Grenadines	  April 12, 2022 
        -    Special Briefing via Telephone  		Telephonic Press Briefing with Katie Tobin, Special Assistant to President Biden and Senior Director for Transborder at the National Security Council	  March 11, 2022 
        -    Special Briefing via Telephone  		Telephonic Press Briefing with Brian A. Nichols, Assistant Secretary of State for Western Hemisphere Affairs, on the IX Summit of the Americas	  Brian A. NicholsJanuary 20, 2022 
        -    Press Statement  		Saint Vincent and the Grenadines Independence Day	  Antony J. BlinkenOctober 27, 2021 
        -    Press Statement  		U.S. Donation of 5.5 Million Doses of COVID-19 Vaccine to CARICOM Countries	  Ned PriceAugust 12, 2021 
        -    Report  		2021 Investment Climate Statements: Saint Vincent and the Grenadines	  July 21, 2021 

previous page1234…6next page

Back to Top
#### § 420.301 Definitions.

For purposes of this subpart—

*Books, documents, and records* means all writings, recordings, transcriptions and tapes of any description necessary to verify the nature and extent of the costs of the services provided by the subcontractor.

*Common ownership* means that an individual or individuals possess significant ownership or equity in the subcontractor and the entity providing the services under the contract.

*Contract for services* means a contract through which a provider obtains the performance of an act or acts, as distinguished from supplies or equipment. It includes any contract for both goods and services to the extent the value or cost of the service component is $10,000 or more within a 12-month period.

*Control* means that an individual or an organization has the power, directly or indirectly, significantly to influence or direct the actions of policies of an organization.

*Provider* means a hospital, skilled nursing facility, home health agency, hospice or comprehensive outpatient rehabilitation facility, or a related organization (as defined in § 413.17 of this chapter) of any of these providers.

*Related to the subcontractor* means that the subcontractor is, to a significant extent, associated or affiliated with, owns, or is owned by, or has control of or is controlled by, the organization furnishing the services, facilities, or supplies.

*Subcontractor* means any entity, including an individual or individuals, that contracts with a provider to supply a service, either to the provider or directly to a beneficiary, for which Medicare reimburses the provider the cost of the service. This includes organizations related to the subcontractor that have a contract with the subcontractor for which the cost or value is $10,000 or more in a 12-month period.

[47 FR 58267, Dec. 30, 1982, as amended at 49 FR 13703, Apr. 6, 1984; 51 FR 34833, Sept. 30, 1986]
- Division Home
- About Us
- Remarks and Releases
- Contact Us

HomeEconomic Sanctions Policy and Implementation...Economic Sanctions Programs

# 						Economic Sanctions Programs					

							The Office of Economic Sanctions Policy and Implementation (EB/TFS/SPI) is responsible for developing and implementing foreign policy-related sanctions adopted to counter threats to national security posed by particular activities and countries. SPI builds international support for implementation of economic sanctions, provides foreign policy guidance to the Department of Treasury and Commerce on sanctions implementation, and works with Congress to draft legislation that advances U.S. foreign policy goals in these areas. SPI maintains and enforces sanctions to maximize their economic impact on our targets and minimize the damage to U.S. economic interests. We also work to remove economic sanctions when appropriate to reward and incentivize improved behavior or demonstrate U.S. support for newly established democratic governments. In addition, SPI conducts outreach on sanctions issues to a wide range of interested parties including NGOs, companies, diaspora groups, and others.						

		Subscribe		

21 items

          -    		Belarus Sanctions	   
          -    		Burma Sanctions	   
          -    		Burundi Sanctions	   
          -    		Central African Republic Sanctions	   
          -    		Cuba Sanctions	   
          -    		Cuba Restricted List	   
          -    		Democratic People’s Republic of Korea Sanctions	   
          -    		Democratic Republic of the Congo Sanctions	   
          -    		Iran Sanctions	   
          -    		Mali Sanctions	   

123next page

Back to Top
Annex II

Reporting accounting framework for critical uses of methyl bromide

(all quantities expressed in metric tons)

Party: United States of America

E F H J K L M

(C + D) (B - E) (E + G) (E-I-J-K)

Amount 

exported

Amount 

destroyed

Amount of 

pre-2005 on 

hand at end 

of year

Amount Country

2012 760 655 104 Israel 759 1 1,249 2,008 759 0 0 0 627

a

b

A B C

Amount of 

CUE on hand 

at end of year

Total 

quantity 

acquired for 

critical use

Quantity 

authorized 

but not 

acquired

Amount of 

pre-2005 on 

hand at start 

of year

Amount 

available for 

use 

Year of 

critical use

Quantity 

exempted for 

year of critical 

use

 a

In addition to the amount in column I, there was an additional 237 MT from stocks accessed in 2012 for critical uses via critical stock allowances. 

G I

Amount used 

for critical 

use

b

Quantity 

acquired by 

production for 

critical use

Quantity acquired for 

critical use by import & 

country of manufacture

D

Total 2012 authorization by the Parties was 1,023 MT. Total U.S. allocation for new production and import for 2012 critical uses was 760 MT; additional amounts of stocks were allowable for 2012 

critical uses in the amount of 263 MT as critical stock allowances.